These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
683 related articles for article (PubMed ID: 26304935)
41. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF. Verma AK; Sun JL; Hernandez A; Teerlink JR; Schulte PJ; Ezekowitz J; Voors A; Starling R; Armstrong P; O'Conner CM; Mentz RJ Clin Cardiol; 2018 Jul; 41(7):945-952. PubMed ID: 29781109 [TBL] [Abstract][Full Text] [Related]
42. Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF). Steinberg BA; Kim S; Thomas L; Fonarow GC; Gersh BJ; Holmqvist F; Hylek E; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel JA; Chang P; Peterson ED; Piccini JP; J Am Heart Assoc; 2015 Sep; 4(9):e002031. PubMed ID: 26370445 [TBL] [Abstract][Full Text] [Related]
43. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure). Richards M; Di Somma S; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Clopton P; Filippatos GS; Anand I; Ng L; Daniels LB; Neath SX; Shah K; Christenson R; Hartmann O; Anker SD; Maisel A JACC Heart Fail; 2013 Jun; 1(3):192-9. PubMed ID: 24621869 [TBL] [Abstract][Full Text] [Related]
44. Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF. Greene SJ; DeVore AD; Sheng S; Fonarow GC; Butler J; Califf RM; Hernandez AF; Matsouaka RA; Samman Tahhan A; Thomas KL; Vaduganathan M; Yancy CW; Peterson ED; O'Connor CM; Mentz RJ JACC Heart Fail; 2019 Nov; 7(11):980-992. PubMed ID: 31606362 [TBL] [Abstract][Full Text] [Related]
45. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). Wan SH; Stevens SR; Borlaug BA; Anstrom KJ; Deswal A; Felker GM; Givertz MM; Bart BA; Tang WH; Redfield MM; Chen HH Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27512103 [TBL] [Abstract][Full Text] [Related]
46. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study. Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606 [TBL] [Abstract][Full Text] [Related]
47. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure. Dandamudi S; Chen HH Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831 [TBL] [Abstract][Full Text] [Related]
48. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure. Arnold LM; Crouch MA; Carroll NV; Oinonen MJ Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484 [TBL] [Abstract][Full Text] [Related]
49. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East. Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119 [TBL] [Abstract][Full Text] [Related]
50. Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF. Reed SD; Kaul P; Li Y; Eapen ZJ; Davidson-Ray L; Schulman KA; Massie BM; Armstrong PW; Starling RC; O'Connor CM; Hernandez AF; Califf RM J Card Fail; 2013 Sep; 19(9):611-20. PubMed ID: 24054337 [TBL] [Abstract][Full Text] [Related]
51. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345 [TBL] [Abstract][Full Text] [Related]
52. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR; Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644 [TBL] [Abstract][Full Text] [Related]
53. Impact of Atrial Fibrillation on Exercise Capacity and Mortality in Heart Failure With Preserved Ejection Fraction: Insights From Cardiopulmonary Stress Testing. Elshazly MB; Senn T; Wu Y; Lindsay B; Saliba W; Wazni O; Cho L J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29089343 [TBL] [Abstract][Full Text] [Related]
54. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. Knudsen CW; Omland T; Clopton P; Westheim A; Wu AH; Duc P; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A J Am Coll Cardiol; 2005 Sep; 46(5):838-44. PubMed ID: 16139134 [TBL] [Abstract][Full Text] [Related]
55. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation. Barywani S; Petzold M Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567 [TBL] [Abstract][Full Text] [Related]
56. Management of suspected acute heart failure dyspnea in the emergency department: results from the French prospective multicenter DeFSSICA survey. Chouihed T; Manzo-Silberman S; Peschanski N; Charpentier S; Elbaz M; Savary D; Bonnefoy-Cudraz E; Laribi S; Henry P; Girerd N; Zannad F; El Khoury C Scand J Trauma Resusc Emerg Med; 2016 Sep; 24(1):112. PubMed ID: 27639971 [TBL] [Abstract][Full Text] [Related]
57. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583 [TBL] [Abstract][Full Text] [Related]
58. Optimal noninvasive assessment of diastolic heart failure in patients with atrial fibrillation: comparison of tissue doppler echocardiography, left atrium size, and brain natriuretic peptide. Watanabe T; Iwai-Takano M; Oikawa M; Yamaki T; Yaoita H; Maruyama Y J Am Soc Echocardiogr; 2008 Jun; 21(6):689-96. PubMed ID: 17904810 [TBL] [Abstract][Full Text] [Related]
59. Catheter ablation for treatment of patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials. Ma Y; Bai F; Qin F; Li Y; Tu T; Sun C; Zhou S; Liu Q BMC Cardiovasc Disord; 2018 Aug; 18(1):165. PubMed ID: 30103676 [TBL] [Abstract][Full Text] [Related]
60. Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. van Diepen S; Bakal JA; McAlister FA; Ezekowitz JA Circulation; 2011 Jul; 124(3):289-96. PubMed ID: 21709059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]